| Product Code: ETC7342134 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Antithrombotic Drugs Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Antithrombotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Antithrombotic Drugs Market - Industry Life Cycle |
3.4 Greece Antithrombotic Drugs Market - Porter's Five Forces |
3.5 Greece Antithrombotic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Greece Antithrombotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Greece Antithrombotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Greece Antithrombotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Greece Antithrombotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Greece Antithrombotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Greece Antithrombotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Rising prevalence of cardiovascular diseases in Greece |
4.2.2 Increasing adoption of anticoagulant therapy for stroke prevention |
4.2.3 Growing geriatric population in Greece requiring antithrombotic treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of antithrombotic drugs in Greece |
4.3.2 Limited access to healthcare facilities in remote areas of Greece |
4.3.3 High cost associated with antithrombotic drugs impacting affordability for patients |
5 Greece Antithrombotic Drugs Market Trends |
6 Greece Antithrombotic Drugs Market, By Types |
6.1 Greece Antithrombotic Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Greece Antithrombotic Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Greece Antithrombotic Drugs Market Revenues & Volume, By Apixaban, 2021- 2031F |
6.1.4 Greece Antithrombotic Drugs Market Revenues & Volume, By Debigatran, 2021- 2031F |
6.1.5 Greece Antithrombotic Drugs Market Revenues & Volume, By Edoxaban, 2021- 2031F |
6.1.6 Greece Antithrombotic Drugs Market Revenues & Volume, By Fondaparinux, 2021- 2031F |
6.1.7 Greece Antithrombotic Drugs Market Revenues & Volume, By Heparin, 2021- 2031F |
6.1.8 Greece Antithrombotic Drugs Market Revenues & Volume, By Rivaroxaban, 2021- 2031F |
6.2 Greece Antithrombotic Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Greece Antithrombotic Drugs Market Revenues & Volume, By Thrombolytic Drugs, 2021- 2031F |
6.2.3 Greece Antithrombotic Drugs Market Revenues & Volume, By Anti-Platelet Drugs, 2021- 2031F |
6.2.4 Greece Antithrombotic Drugs Market Revenues & Volume, By Anticoagulants, 2021- 2031F |
6.2.5 Greece Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Greece Antithrombotic Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Greece Antithrombotic Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.3.3 Greece Antithrombotic Drugs Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Greece Antithrombotic Drugs Market Revenues & Volume, By Deep vein thrombosis (DVT), 2021- 2031F |
6.3.5 Greece Antithrombotic Drugs Market Revenues & Volume, By Pulmonary Embolism (PE), 2021- 2031F |
6.3.6 Greece Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Greece Antithrombotic Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Greece Antithrombotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Greece Antithrombotic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Greece Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Greece Antithrombotic Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Greece Antithrombotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Greece Antithrombotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Greece Antithrombotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Greece Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Greece Antithrombotic Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Greece Antithrombotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Greece Antithrombotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Greece Antithrombotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Greece Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Greece Antithrombotic Drugs Market Import-Export Trade Statistics |
7.1 Greece Antithrombotic Drugs Market Export to Major Countries |
7.2 Greece Antithrombotic Drugs Market Imports from Major Countries |
8 Greece Antithrombotic Drugs Market Key Performance Indicators |
8.1 Number of new antithrombotic drug approvals by the Greek regulatory authorities |
8.2 Percentage of population receiving antithrombotic therapy in Greece |
8.3 Rate of adherence to antithrombotic treatment guidelines in clinical practice |
9 Greece Antithrombotic Drugs Market - Opportunity Assessment |
9.1 Greece Antithrombotic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Greece Antithrombotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Greece Antithrombotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Greece Antithrombotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Greece Antithrombotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Greece Antithrombotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Greece Antithrombotic Drugs Market - Competitive Landscape |
10.1 Greece Antithrombotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Greece Antithrombotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here